SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19

被引:13
作者
Liang, Hong-Yu [1 ]
Wu, Yuyan [2 ,3 ]
Yau, Vicky [4 ]
Yin, Huan-Xin [1 ]
Lowe, Scott [5 ]
Bentley, Rachel [5 ]
Ahmed, Mubashir Ayaz [6 ]
Zhao, Wenjing [7 ]
Sun, Chenyu [7 ]
机构
[1] Anhui Med Univ, Sch Clin Med 2, Hefei 230032, Peoples R China
[2] First Peoples Hosp Hefei, 390 N Huaihe Rd, Hefei 230061, Peoples R China
[3] Philippine Womens Univ, Sch Nursing, 1743 Taft Ave, Manila 1004, Philippines
[4] Columbia Univ, Div Oral & Maxillofacial Surg, Irving Med Ctr, 622W 168th St, New York, NY 10032 USA
[5] Kansas City Univ, Coll Osteopath Med, 1750 Independence Ave, Kansas City, MO 64106 USA
[6] AMITA Hlth St Joseph Hosp Chicago, 2900 N Lake Shore Dr, Chicago, IL 60657 USA
[7] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Nantong Western Rd 98, Yangzhou 225000, Jiangsu, Peoples R China
关键词
COVID-19; SARS-CoV-2; variants; vaccines; molecular therapeutic target; RECEPTOR-BINDING DOMAIN; DELTA VARIANT; MUTATIONS; ESCAPE; SPIKE; ACE2; NEUTRALIZATION; INFECTION; ANAKINRA; SCOTLAND;
D O I
10.3390/vaccines10091538
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Over the past two years, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused hundreds of millions of infections, resulting in an unprecedented pandemic of coronavirus disease 2019 (COVID-19). As the virus spreads through the population, ongoing mutations and adaptations are being discovered. There is now substantial clinical evidence that demonstrates the SARS-CoV-2 variants have stronger transmissibility and higher virulence compared to the wild-type strain of SARS-CoV-2. Hence, development of vaccines against SARS-CoV-2 variants to boost individual immunity has become essential. However, current treatment options are limited for COVID-19 caused by the SARS-CoV-2 variants. In this review, we describe current distribution, variation, biology, and clinical features of COVID-19 caused by SARS-CoV-2 variants (including Alpha (B.1.1.7 Lineage) variant, Beta (B.1.351 Lineage) variant, Gamma (P.1 Lineage) variant, Delta (B.1.617.2 Lineage) variant, and Omicron (B.1.1.529 Lineage) variant and others. In addition, we review currently employed vaccines in clinical or preclinical phases as well as potential targeted therapies in an attempt to provide better preventive and treatment strategies for COVID-19 caused by different SARS-CoV-2 variants.
引用
收藏
页数:27
相关论文
共 50 条
[41]   The Complexity of SARS-CoV-2 Infection and the COVID-19 Pandemic [J].
da Silva Torres, Maria Karoliny ;
Bichara, Carlos David Araujo ;
de Almeida, Maria de Nazare do Socorro ;
Vallinoto, Mariana Cayres ;
Queiroz, Maria Alice Freitas ;
Vallinoto, Izaura Maria Vieira Cayres ;
dos Santos, Eduardo Jose Melo ;
de Carvalho, Carlos Alberto Marques ;
Vallinoto, Antonio Carlos R. .
FRONTIERS IN MICROBIOLOGY, 2022, 13
[42]   Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines [J].
Guan, Xiaoqing ;
Yang, Yang ;
Du, Lanying .
EXPERT REVIEW OF VACCINES, 2023, 22 (01) :422-439
[43]   Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis [J].
Lee, Eunjin ;
Oh, Ji Eun .
MOLECULES AND CELLS, 2021, 44 (06) :392-400
[44]   A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines [J].
Abdolmaleki, Gelareh ;
Taheri, Mina Azam ;
Paridehpour, Sarina ;
Mohammadi, Neshaut Mashreghi ;
Tabatabaei, Yasaman Ahmadi ;
Mousavi, Taraneh ;
Amin, Mohsen .
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 30 (02) :379-406
[45]   COVID-19 Vaccines and Adverse Effects of SARS-CoV-2 in Recovered Patients of COVID-19: An In-depth Review [J].
Raghavendra, B. N. ;
Kancharla, Sudhakar ;
Kolli, Prachetha ;
Mandadapu, Gowtham ;
Jena, Manoj Kumar .
JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2024, 18 (03) :1424-1437
[46]   Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19 [J].
Zepeda-Cervantes, Jesus ;
Martinez-Flores, Daniel ;
Ramirez-Jarquin, Josue Orlando ;
Tecalco-Cruz, angeles C. ;
Alavez-Perez, Noe Santiago ;
Vaca, Luis ;
Sarmiento-Silva, Rosa Elena .
VIRUSES-BASEL, 2022, 14 (01)
[47]   A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants [J].
Rabaan, Ali A. ;
Al Mutair, Abbas ;
Hajissa, Khalid ;
Alfaraj, Amal H. ;
Al-Jishi, Jumana M. ;
Alhajri, Mashael ;
Alwarthan, Sara ;
Alsuliman, Shahab A. ;
Al-Najjar, Amal H. ;
Al Zaydani, Ibrahim A. ;
Al-Absi, Ghadeer Hassan ;
Alshaikh, Sana A. ;
Alkathlan, Mohammed S. ;
Almuthree, Souad A. ;
Alawfi, Abdulsalam ;
Alshengeti, Amer ;
Almubarak, Fatimah Z. ;
Qashgari, Mohammed S. ;
Abdalla, Areeg N. K. ;
Alhumaid, Saad .
VACCINES, 2022, 10 (10)
[48]   A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants? [J].
Noor, Rashed .
CURRENT CLINICAL MICROBIOLOGY REPORTS, 2021, 8 (03) :186-193
[49]   SARS-CoV-2 (COVID-19) and cystic fibrosis [J].
Stanton, Bruce A. ;
Hampton, Thomas H. ;
Ashare, Alix .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 319 (03) :L408-L415
[50]   Impact of SARS-CoV-2/COVID-19 on the placenta [J].
Menter, T. ;
Tzankov, A. ;
Bruder, E. .
PATHOLOGE, 2021, 42 (06) :591-597